Skip to main content

Advertisement

Log in

“Metabolic Syndrome and Its Risk Determinants in Sikkim”: A Glimpse from a Hospital Study

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Sikkim has been reported to have the highest percentage of Diabetes Mellitus and Hypertension in the country. The study aimed to focus its precursor termed ‘Metabolic Syndrome’ (MetS) with special attention to its risk determinants as a measure to promote awareness in preventing the rise in number of these non communicable diseases in the state with only 6,10,577 inhabitants. Of 361 participants, 33.5% were diagnosed MetS as per the harmonized MetS criteria, 64.5% deemed non-MetS comprised of participants with “2 Risk”, “1 Risk” and “0 Risk” for MetS, however not enough (3 or more) to be categorized as MetS. A “large WC + elevated BP + raised FBS”; “large WC + elevated BP” and “large WC” were the different types of risk combinations found frequently in the “3 Risk”, “2 Risk” and “1 Risk” category respectively. MetS was most common among the females and highly found in 51–60 years of age. Ethnically “Bhutia/Lepcha/Tamang/Sherpa” were diagnosed with highest percentage of MetS followed by “Nepalese” and “Others”. The chief contributing factor to compose MetS in the female population was a large WC. We conclude, Diabetes and Hypertension are indeed prevailing in Sikkim and that the presence of either an increased waist circumference or an elevated blood pressure mandates a check for the remaining four risk factors for MetS, rendering worthwhile to keep an account of MetS risk types by stratification to comprehend the influence of socio-cultural and ethno-geographical factors in causing MetS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alexander J. Sikkim reports highest number percent of diabetes, hypertension as per NPCDCS screening. pharmabiz.com. 2013. http://Pharmabiz.com. 12 Oct 2013.

  2. World Health Organization (WHO). Deaths from NCDs http://www.who.int/gho/ncd/mortality/morbidity/en

  3. Joshi SR. India—diabetes capital of the world: now heading towards hypertension. Japi.org. 2007. http://www.japi.org

  4. Grundy S. Diagnosis and management of the Metabolic Syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.

    Article  PubMed  Google Scholar 

  5. Harding J, Shaw J, Peeters A, Cartensen B, Magliano D. Cancer risk among people with Type 1 and Type 2 Diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care. 2014;38(2):264–70.

    Article  PubMed  Google Scholar 

  6. Wilson P. Metabolic Syndrome as a precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus. Circulation. 2005;112(20):3066–72.

    Article  CAS  PubMed  Google Scholar 

  7. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the Metabolic Syndrome. Diabetes Care. 2001;24(4):683–9.

    Article  CAS  PubMed  Google Scholar 

  8. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med. 1998;15(7):539–53.

    Article  CAS  PubMed  Google Scholar 

  9. Grundy S. Diagnosis and management of the Metabolic Syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific statement: executive summary. Circulation. 2005;112(17):e285–90.

    Article  Google Scholar 

  10. Alberti K, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.

    Article  PubMed  Google Scholar 

  11. Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, et al. Harmonizing the Metabolic Syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.

    Article  CAS  PubMed  Google Scholar 

  12. Enas E, Chacko V, Pazhoor S, Chennikkara H, Devarapalli H. Dyslipidemia in South Asian patients. Curr Atheroscler Rep. 2007;9(5):367–74.

    Article  CAS  PubMed  Google Scholar 

  13. GeoHive—India population statistics. Geohive.com. http://www.geohive.com/cntry/india.aspx

  14. Grundy SM. Metabolic Syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629–36.

    Article  CAS  PubMed  Google Scholar 

  15. Aguilar M, Bhuket T, Torres S, Liu B, Wong R. Prevalence of the Metabolic Syndrome in the United States, 2003–2012. JAMA. 2015;313(19):1973.

    Article  CAS  PubMed  Google Scholar 

  16. Misra A, Vikram N. Insulin resistance syndrome (Metabolic Syndrome) and obesity in Asian Indians: evidence and implications. Nutrition. 2004;20(5):482–91.

    Article  CAS  PubMed  Google Scholar 

  17. Alberti K, Zimmet P, Shaw J. Metabolic Syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.

    Article  CAS  PubMed  Google Scholar 

  18. Pathania D, Bunger R, Bunger E, Mishra P, Arora A. An epidemiological study of Metabolic Syndrome in a rural area of Ambala district, Haryana. J Fam Community Med. 2014;21(2):130.

    Article  Google Scholar 

  19. Sawant A, Mankeshwar R, Shah S, Raghavan R, Dhongde G, Raje H, et al. Prevalence of Metabolic Syndrome in Urban India. Cholesterol. 2011;2011:1–7.

    Article  Google Scholar 

  20. Sarkar S, Das M, Mukhopadhyay B, Sekhar Chakraborty C, Majumder P. Prevalence of Metabolic Syndrome in two tribal populations of the sub-Himalayan region of India: ethnic and rural–urban differences. Am J Hum Biol. 2005;17(6):814–7.

    Article  PubMed  Google Scholar 

  21. Despres J. Abdominal obesity: the most prevalent cause of the Metabolic Syndrome and related cardiometabolic risk. Eur Heart J Suppl. 2006;8(Suppl B):B4–12.

    Article  CAS  Google Scholar 

  22. Lee J, Pedley A, Hoffmann U, Massaro J, Fox C. Association of changes in abdominal fat quantity and quality with incident Cardiovascular Disease risk factors. J Am Coll Cardiol. 2016;68(14):1509–21.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Harvey R, Ferrier D. Biochemistry. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011.

    Google Scholar 

  24. Ferrier D, Harvey R. Lippincott’s illustrated reviews: biochemistry. 5th ed. Philadelphia: Wolters Kluwer; 2011.

    Google Scholar 

  25. Roshni M. Metabolic Syndrome and the frequency of occurrence of its components in urban South Indian population. BJMMR. 2014;4(29):4855–67.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to sincerely thank Indian Council of Medical Research (ICMR) for funding our research project [IEC/192/12-05(a)] on ‘Metabolic Syndrome’ (5/7/1099/2013-RCH) undertaken in the Department of Biochemistry—this study represents a section of the work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rinchen D. Bhutia.

Ethics declarations

Conflict of interest

There is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhutia, R.D., Singh, T.A., Sherpa, M.L. et al. “Metabolic Syndrome and Its Risk Determinants in Sikkim”: A Glimpse from a Hospital Study. Ind J Clin Biochem 32, 480–486 (2017). https://doi.org/10.1007/s12291-017-0635-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-017-0635-8

Keywords

Navigation